1-3 of 3
Rea Delphine
Close
Sort by
Journal Articles

Incidence of Hyperglycemia by 3 Years in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Nilotinib (NIL) or Imatinib (IM) in ENESTnd

Rea Delphine, MD, PhD, Jean-francois Gautier, Massimo Breccia, Giuseppe Saglio, MD, Timothy P. Hughes, MD, MBBS, Hagop M. Kantarjian, MD, Charisse Kemp, Haitao Gao, Carmen Piccolo, MD, Richard A. Larson, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2012) 120 (21): 1686.
https://doi.org/10.1182/blood.V120.21.1686.1686
Published: 2012
Journal Articles

Pegylated Interferon a2a (PegIFN) At the Dose of 45μg Per Week in Combination with Imatinib 400mg Is the Recommended Initial Dose for Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML-CP): Results From the French SPIRIT Trial of the French CML Group (FI LMC)

Hyacinthe Johnson-Ansah, MD, Joelle Guilhot, Philippe Rousselot, MD, PhD, Rea Delphine, MD, PhD, Francoise Rigal-Huguet, MD, Franck E. Nicolini, MD, PhD, Anne Vekhoff, MD, Agnès Guerci-Bresler, MD, PhD, Michele Schoenwald, MD, Eric Jourdan, Laurence Legros, Valérie Coiteux, MD, Francois-Xavier Mahon, MD, PhD, Claude Preudhomme, Francois Guilhot
Journal: Blood
Blood (2011) 118 (21): 456.
https://doi.org/10.1182/blood.V118.21.456.456
Published: 2011
Journal Articles

Impact of Prior Second-Generation Tyrosine Kinase Inhibitors on the Outcome of Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia

Deau Benedicte, Bachy Emmanuel, Raus Nicole, Nicolini Franck-emmanuel, Rea Delphine, Reman Oumedaly, Maillard Natacha, Shanti Ame, Fegueux Nathalie, Coiteux Valerie, Gardembas Martine, Charbonnier Aude, Huyn Anne, Cahn Jean Yves, Buzyn Agnes
Journal: Blood
Blood (2010) 116 (21): 2267.
https://doi.org/10.1182/blood.V116.21.2267.2267
Published: 2010